12.4.2017 08:02 | Business Wire
SynteractHCR Continues to Show International Clinical Trial Expertise by Participating in European Conferences This Spring
SynteractHCR , a full-service, international contract research organization (CRO), will present and exhibit at several European biopharma events this spring. The events include Clinical Trials in Central and Eastern Europe on April 11 – 12, ePharma Day 2017 on May 3 and Outsourcing in Clinical Trials (OCT) Europe on May 16 – 17.
Dr. Martine Dehlinger-Kremer , global vice president of medical and regulatory affairs, will present at Session 2, “Update on Regulation, Compliance, Legal & Ethical Legislative Developments” on Tuesday, April 25, at 9:55 a.m. at Clinical Trials in Central and Eastern Europe in Budapest, Hungary. With more than 26 years of regulatory affairs leadership experience, Dr. Dehlinger-Kremer will provide invaluable insight on the latest clinical trial regulatory initiatives. Attendees will leave the presentation with a better understanding on how a regulatory agency can support earlier access to medical products.
At ePharma Day 2017 in Frankfurt, Germany, Dr. Dehlinger-Kremer, with others serving on the scientific board, will provide opening remarks and welcome conference attendees on Wednesday, May 3, at 9:30 a.m. That same day, SynteractHCR Director Regulatory Affairs, Dr. Ludwig Baumann, will present “EU Portal and Database – User Acceptance Testing and Status of Implementation” at 12:10 p.m.
SynteractHCR will make its final spring European conference stop in Barcelona for OCT Europe , and will exhibit at booth #7. OCT Europe brings together executives working within clinical operations and outsourcing across Europe, providing the opportunity for attendees to discuss current challenges in the industry.
Attendees interested in meeting with the SynteractHCR team at these events may contact Chief Commercial Officer Matt Smith at 760-268-8200 or firstname.lastname@example.org .
SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and 60 countries, offering expertise across multiple therapeutic areas, with notable depth in oncology, immunotherapy, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision ” philosophy, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data to help bring tomorrow’s treatments to patients.
Nikki Sachman, 760-230-2424
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
NY-THE-VALENCE-GROUP18.8.2017 15:32 | pressemeddelelse
The Valence Group Issues Fairness Opinion to SK Capital in Connection with Archroma
DELTICOM-AG/MOTO-TYRES18.8.2017 11:24 | pressemeddelelse
Biker Summer 2017 campaign: What’s happening during Biker Summer 2017? Moto-tyres.co.uk is giving away exciting prizes!
NC-LENOVO-NCTA18.8.2017 02:06 | pressemeddelelse
Lenovo Continues to Gain Momentum in First Quarter FY 2017/18
SPIRENT-COMMUNICATIONS17.8.2017 17:59 | pressemeddelelse
Spirent Tests Wi-Fi Network Performance with O2 at the Coca-Cola London Eye
BIZWIRETV17.8.2017 14:10 | pressemeddelelse
Watch BizWireTV: A Camera You Can Wear and Krispy Kreme’s Famous Donuts Get Eclipsed with Chocolate
PA-PSIOXUS-THERAPEUTICS17.8.2017 09:02 | pressemeddelelse
PsiOxus Therapeutics Announce Two New Board Appointments: New Board Appointments Strengthen Company’s US Presence
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum